AbbVie Stock Crumbles On Mixed Earnings, Slashes 2022 Earnings Outlook

AbbVie inventory crumbled early Friday just after the biopharma large minimize its earnings outlook and arrived up small on gross sales for its 1st quarter.

X

The business reported adjusted gain of $3.16 per share on $13.54 billion in income. On typical, analysts polled by FactSet envisioned AbbVie (ABBV) to make $3.14 a share on $13.66 billion in profits.

In the yr-earlier time period, AbbVie earnings ended up $2.89 per share on $13.01 billion in profits.

For the year, AbbVie reduce its earnings outlook to $13.92-$14.12 for each share, which features an 8-cent strike because of to analysis and growth, as properly as a milestone payment from the first quarter. AbbVie inventory analysts experienced predicted modified profit of $14.16 a share on $60.23 billion in product sales.

In premarket trading on present day inventory marketplace, AbbVie stock toppled 4.4% around 149.50.

More to abide by.

Comply with Allison Gatlin on Twitter at @IBD_AGatlin.

YOU May perhaps ALSO LIKE:

Eli Lilly Extends Its Breakout On First-Quarter Conquer, Bullish News In Being overweight

Sanofi Scores A Huge Beat As Dupixent Snags The Spotlight, Yet again

IBD Electronic: Unlock IBD’s Quality Stock Lists, Resources And Assessment These days

Possibilities Investing: How To Start out Employing Options, How To Manage Hazard

How To Investigation Development Shares: Why This IBD Resource Simplifies The Research For Best Stocks